| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 5-diphosphoinositol pentakisphosphate 1-kinase activity | 2.49e-06 | 2 | 32 | 2 | GO:0033857 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 3-kinase activity | 1.49e-05 | 4 | 32 | 2 | GO:0052724 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 1-kinase activity | 1.49e-05 | 4 | 32 | 2 | GO:0052723 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 5-kinase activity | 2.48e-05 | 5 | 32 | 2 | GO:0000832 | |
| GeneOntologyMolecularFunction | diphosphoinositol pentakisphosphate kinase activity | 2.48e-05 | 5 | 32 | 2 | GO:0000829 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate kinase activity | 2.48e-05 | 5 | 32 | 2 | GO:0000828 | |
| GeneOntologyMolecularFunction | inositol-1,3,4,5,6-pentakisphosphate kinase activity | 2.48e-05 | 5 | 32 | 2 | GO:0000827 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 1.04e-04 | 1244 | 32 | 9 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 1.23e-04 | 1271 | 32 | 9 | GO:0000987 | |
| GeneOntologyMolecularFunction | inositol phosphate kinase activity | 1.36e-04 | 11 | 32 | 2 | GO:0180030 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 2.31e-04 | 560 | 32 | 6 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 2.44e-04 | 566 | 32 | 6 | GO:0001216 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 3.48e-04 | 1459 | 32 | 9 | GO:0000977 | |
| GeneOntologyMolecularFunction | semaphorin receptor binding | 6.16e-04 | 23 | 32 | 2 | GO:0030215 | |
| GeneOntologyMolecularFunction | chemorepellent activity | 9.83e-04 | 29 | 32 | 2 | GO:0045499 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 1.39e-03 | 1412 | 32 | 8 | GO:0000981 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, phosphate group as acceptor | 1.96e-03 | 41 | 32 | 2 | GO:0016776 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 5.01e-03 | 66 | 32 | 2 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 5.01e-03 | 66 | 32 | 2 | GO:0001098 | |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 7.63e-03 | 82 | 32 | 2 | GO:1990756 | |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | 1.01e-02 | 95 | 32 | 2 | GO:0140767 | |
| GeneOntologyMolecularFunction | calcium-dependent protein binding | 1.07e-02 | 98 | 32 | 2 | GO:0048306 | |
| GeneOntologyBiologicalProcess | stem cell differentiation | 6.65e-06 | 306 | 32 | 6 | GO:0048863 | |
| GeneOntologyBiologicalProcess | neural crest cell development | 1.06e-05 | 89 | 32 | 4 | GO:0014032 | |
| GeneOntologyBiologicalProcess | stem cell development | 1.75e-05 | 101 | 32 | 4 | GO:0048864 | |
| GeneOntologyBiologicalProcess | neural crest cell differentiation | 1.97e-05 | 104 | 32 | 4 | GO:0014033 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 2.01e-05 | 372 | 32 | 6 | GO:0060485 | |
| GeneOntologyBiologicalProcess | positive regulation of protein monoubiquitination | 2.33e-05 | 5 | 32 | 2 | GO:1902527 | |
| GeneOntologyBiologicalProcess | regulation of protein monoubiquitination | 3.48e-05 | 6 | 32 | 2 | GO:1902525 | |
| GeneOntologyBiologicalProcess | mesenchymal cell differentiation | 8.62e-05 | 296 | 32 | 5 | GO:0048762 | |
| GeneOntologyBiologicalProcess | inositol metabolic process | 1.04e-04 | 10 | 32 | 2 | GO:0006020 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | 3.09e-04 | 1483 | 32 | 9 | GO:0048646 | |
| GeneOntologyBiologicalProcess | neural crest formation | 3.13e-04 | 17 | 32 | 2 | GO:0014029 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 3.96e-04 | 906 | 32 | 7 | GO:0043009 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 4.60e-04 | 929 | 32 | 7 | GO:0009792 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 4.81e-04 | 21 | 32 | 2 | GO:0042447 | |
| GeneOntologyBiologicalProcess | anterior/posterior pattern specification | 5.54e-04 | 247 | 32 | 4 | GO:0009952 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system morphogenesis | 6.37e-04 | 109 | 32 | 3 | GO:0048704 | |
| GeneOntologyBiologicalProcess | regionalization | 7.86e-04 | 478 | 32 | 5 | GO:0003002 | |
| GeneOntologyBiologicalProcess | vesicle targeting, rough ER to cis-Golgi | 7.99e-04 | 27 | 32 | 2 | GO:0048207 | |
| GeneOntologyBiologicalProcess | COPII vesicle coating | 7.99e-04 | 27 | 32 | 2 | GO:0048208 | |
| GeneOntologyBiologicalProcess | spinal cord development | 8.22e-04 | 119 | 32 | 3 | GO:0021510 | |
| GeneOntologyBiologicalProcess | inositol phosphate biosynthetic process | 1.05e-03 | 31 | 32 | 2 | GO:0032958 | |
| GeneOntologyCellularComponent | vesicle coat | 1.46e-04 | 67 | 32 | 3 | GO:0030120 | |
| GeneOntologyCellularComponent | COPII vesicle coat | 2.69e-04 | 16 | 32 | 2 | GO:0030127 | |
| GeneOntologyCellularComponent | membrane coat | 5.65e-04 | 106 | 32 | 3 | GO:0030117 | |
| GeneOntologyCellularComponent | coated membrane | 5.65e-04 | 106 | 32 | 3 | GO:0048475 | |
| GeneOntologyCellularComponent | chromatin | 1.40e-03 | 1480 | 32 | 8 | GO:0000785 | |
| GeneOntologyCellularComponent | Cul3-RING ubiquitin ligase complex | 1.62e-03 | 39 | 32 | 2 | GO:0031463 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 4.27e-03 | 215 | 32 | 3 | GO:0030662 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 4.31e-03 | 64 | 32 | 2 | GO:0012507 | |
| Domain | ZF_C2H2_AKAP95 | 7.48e-06 | 3 | 30 | 2 | PS51799 | |
| Domain | AKAP95 | 7.48e-06 | 3 | 30 | 2 | IPR007071 | |
| Domain | AKAP95 | 7.48e-06 | 3 | 30 | 2 | PF04988 | |
| Domain | Plexin_repeat | 1.80e-05 | 32 | 30 | 3 | IPR002165 | |
| Domain | PSI | 1.80e-05 | 32 | 30 | 3 | PF01437 | |
| Domain | Acid_Pase_AS | 3.73e-05 | 6 | 30 | 2 | IPR033379 | |
| Domain | PSI | 4.74e-05 | 44 | 30 | 3 | IPR016201 | |
| Domain | HIS_ACID_PHOSPHAT_2 | 5.21e-05 | 7 | 30 | 2 | PS00778 | |
| Domain | HIS_ACID_PHOSPHAT_1 | 5.21e-05 | 7 | 30 | 2 | PS00616 | |
| Domain | PSI | 5.42e-05 | 46 | 30 | 3 | SM00423 | |
| Domain | His_Pase_clade-2 | 6.94e-05 | 8 | 30 | 2 | IPR000560 | |
| Domain | His_Phos_2 | 6.94e-05 | 8 | 30 | 2 | PF00328 | |
| Domain | Semaphorin | 4.65e-04 | 20 | 30 | 2 | IPR027231 | |
| Domain | His_PPase_superfam | 4.65e-04 | 20 | 30 | 2 | IPR029033 | |
| Domain | - | 4.65e-04 | 20 | 30 | 2 | 3.40.50.1240 | |
| Domain | SEMA | 1.13e-03 | 31 | 30 | 2 | PS51004 | |
| Domain | Sema | 1.13e-03 | 31 | 30 | 2 | SM00630 | |
| Domain | Semap_dom | 1.13e-03 | 31 | 30 | 2 | IPR001627 | |
| Domain | Sema | 1.13e-03 | 31 | 30 | 2 | PF01403 | |
| Domain | Homeobox_CS | 3.24e-03 | 186 | 30 | 3 | IPR017970 | |
| Domain | Homeobox | 6.14e-03 | 234 | 30 | 3 | PF00046 | |
| Domain | HOMEOBOX_1 | 6.29e-03 | 236 | 30 | 3 | PS00027 | |
| Domain | HOX | 6.36e-03 | 237 | 30 | 3 | SM00389 | |
| Domain | Homeobox_dom | 6.51e-03 | 239 | 30 | 3 | IPR001356 | |
| Domain | HOMEOBOX_2 | 6.51e-03 | 239 | 30 | 3 | PS50071 | |
| Domain | EF-hand_7 | 8.20e-03 | 85 | 30 | 2 | PF13499 | |
| Domain | Homeobox_metazoa | 9.15e-03 | 90 | 30 | 2 | IPR020479 | |
| Domain | - | 1.03e-02 | 283 | 30 | 3 | 1.10.10.60 | |
| Domain | Homeodomain-like | 1.58e-02 | 332 | 30 | 3 | IPR009057 | |
| Pathway | REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL | 9.44e-05 | 10 | 21 | 2 | M27051 | |
| Pathway | REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL | 9.44e-05 | 10 | 21 | 2 | MM14709 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 1.90e-04 | 14 | 21 | 2 | MM15047 | |
| Pathway | WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM | 2.50e-04 | 16 | 21 | 2 | M39815 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 3.56e-04 | 19 | 21 | 2 | M10959 | |
| Pubmed | 5.72e-07 | 18 | 32 | 3 | 23359544 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 18981179 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 17702752 | ||
| Pubmed | ALG-2 and peflin regulate COPII targeting and secretion in response to calcium signaling. | 8.20e-07 | 2 | 32 | 2 | 34762908 | |
| Pubmed | Th1 cells promote neurite outgrowth from cortical neurons via a mechanism dependent on semaphorins. | 8.20e-07 | 2 | 32 | 2 | 20946887 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 28126903 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 11883899 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 17690096 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 11278427 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 1.26e-06 | 908 | 32 | 8 | 19274049 | |
| Pubmed | PPIP5K2 and PCSK1 are Candidate Genetic Contributors to Familial Keratoconus. | 2.46e-06 | 3 | 32 | 2 | 31852976 | |
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | 3.02e-06 | 1021 | 32 | 8 | 26760575 | |
| Pubmed | 7.22e-06 | 808 | 32 | 7 | 20412781 | ||
| Pubmed | Oct4 is required ~E7.5 for proliferation in the primitive streak. | 8.19e-06 | 5 | 32 | 2 | 24244203 | |
| Pubmed | The PEF family proteins sorcin and grancalcin interact in vivo and in vitro. | 8.19e-06 | 5 | 32 | 2 | 12804766 | |
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 28733998 | ||
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 12445460 | ||
| Pubmed | Generation of conditional Hoxc8 loss-of-function and Hoxc8-->Hoxc9 replacement alleles in mice. | 1.23e-05 | 6 | 32 | 2 | 19621436 | |
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 34490995 | ||
| Pubmed | The expression profile of the tumor suppressor gene Lzts1 suggests a role in neuronal development. | 2.29e-05 | 8 | 32 | 2 | 22419569 | |
| Pubmed | 3.67e-05 | 10 | 32 | 2 | 26005002 | ||
| Pubmed | A role for neuregulin1 signaling in muscle spindle differentiation. | 3.67e-05 | 10 | 32 | 2 | 12495620 | |
| Pubmed | 4.49e-05 | 11 | 32 | 2 | 11969257 | ||
| Pubmed | 5.38e-05 | 12 | 32 | 2 | 27856734 | ||
| Pubmed | The Polycomb-group homolog Bmi-1 is a regulator of murine Hox gene expression. | 6.36e-05 | 13 | 32 | 2 | 8887324 | |
| Pubmed | 6.36e-05 | 13 | 32 | 2 | 25805847 | ||
| Pubmed | 7.41e-05 | 14 | 32 | 2 | 8099712 | ||
| Pubmed | Dlk1-Dio3 locus-derived lncRNAs perpetuate postmitotic motor neuron cell fate and subtype identity. | 7.41e-05 | 14 | 32 | 2 | 30311912 | |
| Pubmed | 7.41e-05 | 14 | 32 | 2 | 16790475 | ||
| Pubmed | 7.87e-05 | 90 | 32 | 3 | 33087562 | ||
| Pubmed | Tcf7l1 prepares epiblast cells in the gastrulating mouse embryo for lineage specification. | 8.55e-05 | 15 | 32 | 2 | 23487311 | |
| Pubmed | 9.76e-05 | 16 | 32 | 2 | 24257626 | ||
| Pubmed | 1.11e-04 | 17 | 32 | 2 | 17626057 | ||
| Pubmed | 1.11e-04 | 17 | 32 | 2 | 29915126 | ||
| Pubmed | 1.11e-04 | 17 | 32 | 2 | 20573702 | ||
| Pubmed | Changes in thyroid status during perinatal development of MCT8-deficient male mice. | 1.24e-04 | 18 | 32 | 2 | 23696569 | |
| Pubmed | Growth disturbance in fetal liver hematopoiesis of Mll-mutant mice. | 1.24e-04 | 18 | 32 | 2 | 9639506 | |
| Pubmed | 1.24e-04 | 18 | 32 | 2 | 27895551 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 1.31e-04 | 544 | 32 | 5 | 28473536 | |
| Pubmed | 1.39e-04 | 19 | 32 | 2 | 15051154 | ||
| Pubmed | Post-gastrulation synthetic embryos generated ex utero from mouse naive ESCs. | 1.39e-04 | 19 | 32 | 2 | 35988542 | |
| Pubmed | Oct4 Is a Key Regulator of Vertebrate Trunk Length Diversity. | 1.39e-04 | 19 | 32 | 2 | 27453501 | |
| Pubmed | 1.54e-04 | 20 | 32 | 2 | 10498685 | ||
| Pubmed | 1.63e-04 | 115 | 32 | 3 | 20000738 | ||
| Pubmed | NRG1 signalling regulates the establishment of Sertoli cell stock in the mouse testis. | 1.70e-04 | 21 | 32 | 2 | 30040984 | |
| Pubmed | Motor neurons use push-pull signals to direct vascular remodeling critical for their connectivity. | 1.70e-04 | 21 | 32 | 2 | 36240771 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 1.72e-04 | 922 | 32 | 6 | 27609421 | |
| Pubmed | 1.87e-04 | 22 | 32 | 2 | 2576652 | ||
| Pubmed | Ets2 is necessary in trophoblast for normal embryonic anteroposterior axis development. | 1.87e-04 | 22 | 32 | 2 | 16481355 | |
| Pubmed | 1.87e-04 | 22 | 32 | 2 | 35120648 | ||
| Pubmed | 1.87e-04 | 22 | 32 | 2 | 21896659 | ||
| Pubmed | 2.05e-04 | 23 | 32 | 2 | 22817342 | ||
| Pubmed | 2.05e-04 | 23 | 32 | 2 | 28190640 | ||
| Pubmed | BMP signalling inhibits premature neural differentiation in the mouse embryo. | 2.24e-04 | 24 | 32 | 2 | 17699604 | |
| Pubmed | The absence of Prep1 causes p53-dependent apoptosis of mouse pluripotent epiblast cells. | 2.24e-04 | 24 | 32 | 2 | 20826531 | |
| Pubmed | Dimerization quality control ensures neuronal development and survival. | 2.24e-04 | 24 | 32 | 2 | 30190310 | |
| Pubmed | 2.24e-04 | 24 | 32 | 2 | 9367423 | ||
| Pubmed | A semaphorin code defines subpopulations of spinal motor neurons during mouse development. | 2.24e-04 | 24 | 32 | 2 | 15869472 | |
| Pubmed | Spry1 and Spry2 are necessary for lens vesicle separation and corneal differentiation. | 2.43e-04 | 25 | 32 | 2 | 21743007 | |
| Pubmed | 2.63e-04 | 26 | 32 | 2 | 22992956 | ||
| Pubmed | 2.63e-04 | 26 | 32 | 2 | 8646877 | ||
| Pubmed | Multipotent peripheral glial cells generate neuroendocrine cells of the adrenal medulla. | 2.63e-04 | 26 | 32 | 2 | 28684471 | |
| Pubmed | Complementary functions of Otx2 and Cripto in initial patterning of mouse epiblast. | 3.05e-04 | 28 | 32 | 2 | 11412024 | |
| Pubmed | Mediator and cohesin connect gene expression and chromatin architecture. | 3.05e-04 | 28 | 32 | 2 | 20720539 | |
| Pubmed | Noggin is required for correct guidance of dorsal root ganglion axons. | 3.28e-04 | 29 | 32 | 2 | 12435358 | |
| Pubmed | 3.28e-04 | 29 | 32 | 2 | 2574852 | ||
| Pubmed | GDE2 regulates subtype-specific motor neuron generation through inhibition of Notch signaling. | 3.51e-04 | 30 | 32 | 2 | 21943603 | |
| Pubmed | Critical role of the p400/mDomino chromatin-remodeling ATPase in embryonic hematopoiesis. | 4.00e-04 | 32 | 32 | 2 | 17535249 | |
| Pubmed | 4.00e-04 | 32 | 32 | 2 | 38110169 | ||
| Pubmed | Sf3b4 regulates chromatin remodeler splicing and Hox expression. | 4.00e-04 | 32 | 32 | 2 | 37167859 | |
| Pubmed | 4.25e-04 | 33 | 32 | 2 | 18662545 | ||
| Pubmed | 4.25e-04 | 33 | 32 | 2 | 25179941 | ||
| Pubmed | Nuclear pore composition regulates neural stem/progenitor cell differentiation in the mouse embryo. | 4.52e-04 | 34 | 32 | 2 | 18539113 | |
| Pubmed | 4.52e-04 | 34 | 32 | 2 | 23293290 | ||
| Pubmed | MEGF10 and MEGF11 mediate homotypic interactions required for mosaic spacing of retinal neurons. | 4.79e-04 | 35 | 32 | 2 | 22407321 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 4.87e-04 | 167 | 32 | 3 | 20362541 | |
| Pubmed | Global control of motor neuron topography mediated by the repressive actions of a single hox gene. | 5.07e-04 | 36 | 32 | 2 | 20826310 | |
| Pubmed | 5.65e-04 | 38 | 32 | 2 | 20214802 | ||
| Pubmed | 5.65e-04 | 38 | 32 | 2 | 15042701 | ||
| Pubmed | 5.65e-04 | 38 | 32 | 2 | 11857506 | ||
| Pubmed | 5.67e-04 | 418 | 32 | 4 | 34709266 | ||
| Pubmed | 5.95e-04 | 39 | 32 | 2 | 33257809 | ||
| Pubmed | Quantification of Hox and surfactant protein-B transcription during murine lung development. | 6.26e-04 | 40 | 32 | 2 | 19204410 | |
| Pubmed | NOTCH activation interferes with cell fate specification in the gastrulating mouse embryo. | 6.26e-04 | 40 | 32 | 2 | 26534985 | |
| Pubmed | Cdx and T Brachyury Co-activate Growth Signaling in the Embryonic Axial Progenitor Niche. | 6.26e-04 | 40 | 32 | 2 | 28009287 | |
| Pubmed | 6.58e-04 | 41 | 32 | 2 | 8724849 | ||
| Pubmed | 6.58e-04 | 41 | 32 | 2 | 32479258 | ||
| Pubmed | 7.23e-04 | 43 | 32 | 2 | 22701719 | ||
| Pubmed | 7.57e-04 | 44 | 32 | 2 | 1973146 | ||
| Pubmed | Activated Braf induces esophageal dilation and gastric epithelial hyperplasia in mice. | 7.92e-04 | 45 | 32 | 2 | 28973166 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 8.23e-04 | 462 | 32 | 4 | 31138677 | |
| Pubmed | NANOG initiates epiblast fate through the coordination of pluripotency genes expression. | 8.28e-04 | 46 | 32 | 2 | 35729116 | |
| Pubmed | 8.64e-04 | 47 | 32 | 2 | 1358459 | ||
| Pubmed | The emergent landscape of the mouse gut endoderm at single-cell resolution. | 9.01e-04 | 48 | 32 | 2 | 30959515 | |
| Interaction | KLHL12 interactions | 1.89e-05 | 104 | 31 | 4 | int:KLHL12 | |
| Cytoband | 1p32.3 | 8.40e-04 | 61 | 32 | 2 | 1p32.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 3.16e-03 | 423 | 32 | 3 | chr12q13 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 3.43e-04 | 20 | 25 | 2 | 736 | |
| GeneFamily | HOXL subclass homeoboxes | 2.33e-03 | 52 | 25 | 2 | 518 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_UP | 5.83e-05 | 174 | 32 | 4 | M8885 | |
| Coexpression | GSE27786_LSK_VS_NKTCELL_DN | 9.62e-05 | 198 | 32 | 4 | M4756 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 1.21e-04 | 210 | 32 | 4 | M2010 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K27ME3 | 1.23e-04 | 79 | 32 | 3 | M1932 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K27ME3 | 1.27e-04 | 80 | 32 | 3 | MM817 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 1.37e-04 | 217 | 32 | 4 | MM861 | |
| Coexpression | SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN | 1.37e-04 | 82 | 32 | 3 | M244 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | 1.49e-04 | 422 | 32 | 5 | M7396 | |
| Coexpression | SMID_BREAST_CANCER_BASAL_DN | 1.76e-04 | 699 | 32 | 6 | M4960 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | 1.77e-04 | 438 | 32 | 5 | M1954 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | 1.81e-04 | 440 | 32 | 5 | MM832 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | 1.88e-04 | 444 | 32 | 5 | MM1051 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-05 | 198 | 32 | 4 | 2ada078be27588ab46f2d4e53d20f8e9bc8761df | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.24e-05 | 200 | 32 | 4 | 16a3685c41194a0a4a772e4eee372160263480e0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.85e-04 | 155 | 32 | 3 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.85e-04 | 155 | 32 | 3 | d8b5145258f075b15080f8739f537f48dd22225e | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.85e-04 | 155 | 32 | 3 | ced64e26962c5c6e6d539f361fe57ab0b399e999 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.85e-04 | 155 | 32 | 3 | 0f24ef6486aef354f0911c06932cb01d1a0525ac | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.96e-04 | 158 | 32 | 3 | dc559503bab3ec1b9ea54ef2e896d1be33e5344c | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.07e-04 | 161 | 32 | 3 | 58381131e651744b5141b202f9d6063f55432db5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.10e-04 | 162 | 32 | 3 | c5eee02836efde2108534679850c28d2b2cfce3f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-04 | 170 | 32 | 3 | be2a34c70665d8d11332b1a70eda03d77cb7f7dd | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.64e-04 | 175 | 32 | 3 | 2fbffcb843f364645b99d1211698d96092abc5ef | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-stromal_related-Germ|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.64e-04 | 175 | 32 | 3 | d0d5ae2a9357aa183ab720c891d86b80c9822930 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.78e-04 | 178 | 32 | 3 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.78e-04 | 178 | 32 | 3 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.78e-04 | 178 | 32 | 3 | 7975bf0a3146ee0efa4f547af5977e6bf0ba71fd | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.82e-04 | 179 | 32 | 3 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.87e-04 | 180 | 32 | 3 | c3d1521ac90f2e3fc31158e6e61907e05c37af39 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.87e-04 | 180 | 32 | 3 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.87e-04 | 180 | 32 | 3 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-NK_bright-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.91e-04 | 181 | 32 | 3 | 4795833e0ec49287bd7809ecfe523fc527565fba | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.91e-04 | 181 | 32 | 3 | eea943fdcbef0bbaa8578f3296923e874893b405 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-NK_bright|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.91e-04 | 181 | 32 | 3 | 208cdccc2f0d0f2d8ec321064c63aed206d46c32 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.91e-04 | 181 | 32 | 3 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.01e-04 | 183 | 32 | 3 | bc7dd6a40ec9c773d005c1a46f305d40cdd0a326 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-04 | 184 | 32 | 3 | 7aa245b73e10fd73d292e822de6b72920aa12355 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Mesenchymal-Mes-Pericyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.11e-04 | 185 | 32 | 3 | 0e26a71fea526ebfe3b2d1c8d0d6d9b70282bbe9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Mesenchymal-Mes-Pericyte-Peri_L1-6_MUSTN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.11e-04 | 185 | 32 | 3 | b3320b794b22e654a33f28b575c9f00023baf5f0 | |
| ToppCell | Thalamus-Endothelial|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.16e-04 | 186 | 32 | 3 | dcc6e4417c4123d5ca6b96fa8ca4874626aaebdb | |
| ToppCell | Frontal_cortex-Endothelial|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.26e-04 | 188 | 32 | 3 | a43392dbd10fc7dbfb31be39b8af8a7ea121c894 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 188 | 32 | 3 | 315ce1736e3a84a63a8d5dfa70d411b501cb2532 | |
| ToppCell | Entopeduncular-Endothelial|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.26e-04 | 188 | 32 | 3 | 94774652fd42bad5012356672ffac8b6d2c22d37 | |
| ToppCell | Substantia_nigra-Endothelial|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.31e-04 | 189 | 32 | 3 | bef8234bd9c4d6e3cdef0791d8066b39ba56ebba | |
| ToppCell | Globus_pallidus-Endothelial|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.31e-04 | 189 | 32 | 3 | ad7dc9d25edd68fb624380a082c389fe7d640e7d | |
| ToppCell | Striatum-Endothelial|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.31e-04 | 189 | 32 | 3 | 95ee3b6d7fbbfcf91c780dfcd0926acec05f0a2d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.36e-04 | 190 | 32 | 3 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.36e-04 | 190 | 32 | 3 | 5eaf03a98ab24d7cfd471cb035aa1d2ec6e6e28c | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.36e-04 | 190 | 32 | 3 | 71a00f63fdd4eb4cc6f190d37e7a0417cdaafacb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.46e-04 | 192 | 32 | 3 | c4efc170852abbcf0c53c2b0f8a0cc9fe7f116c8 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.46e-04 | 192 | 32 | 3 | 4c9d748f209cc1e13d28c8c7f5180ab8522e0fbf | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_mature_DC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.52e-04 | 193 | 32 | 3 | d9be4d1de863fffc2240d6fd1a2f8dfb2d2bc916 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.52e-04 | 193 | 32 | 3 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.52e-04 | 193 | 32 | 3 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.52e-04 | 193 | 32 | 3 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.52e-04 | 193 | 32 | 3 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.57e-04 | 194 | 32 | 3 | fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c | |
| ToppCell | LAM-LAM|LAM / Condition, Lineage and Cell class | 3.57e-04 | 194 | 32 | 3 | 4c6561a64711c72c4ef4a3e67c41d2e8d31fba57 | |
| ToppCell | LAM-LAM-LAM+|LAM / Condition, Lineage and Cell class | 3.57e-04 | 194 | 32 | 3 | 4ba73a9145ed44896e359f6df9c1f32bbe24a189 | |
| ToppCell | Mild/Remission-B_memory-0|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.57e-04 | 194 | 32 | 3 | 4866093b50cdf895f06b60684cc3aaa9769aa4dc | |
| ToppCell | Cerebellum-Endothelial|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.62e-04 | 195 | 32 | 3 | 2192fd9b4682054776f0716933aed5a4a9412657 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.62e-04 | 195 | 32 | 3 | 98dd3b7d5ef587825dac052dea4d4ff883f6d4d6 | |
| ToppCell | Posterior_cortex-Endothelial|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.62e-04 | 195 | 32 | 3 | 988e3449691cc228cb55e5e30355136c97b12262 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD4+_Th|T/NK_cells / Location, Cell class and cell subclass | 3.62e-04 | 195 | 32 | 3 | 5de6841fa04f6fe6f0c2aa6c300667a25ae6d52e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.68e-04 | 196 | 32 | 3 | 40e6900a0d56088a40d37ec312f53207ea952602 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.68e-04 | 196 | 32 | 3 | cb5860f580b477bfa52b22cdc21b808e1371e6e0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.68e-04 | 196 | 32 | 3 | 9a420a4eb46cb554bec641726fea5398ff60f630 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.68e-04 | 196 | 32 | 3 | bcd274db4955ea76ca26267a272c7d1929db24f4 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.68e-04 | 196 | 32 | 3 | 80b9139d91dda4de69830d2d443859e047ab5503 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 196 | 32 | 3 | 81f9754567bbfa67edd304b9ef7b03e7bd9a3b52 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM1|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.68e-04 | 196 | 32 | 3 | ea3fbe81b4ecb6ccc8031f6d99da93c9f9f8c1aa | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.68e-04 | 196 | 32 | 3 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.68e-04 | 196 | 32 | 3 | 0b247cf981981ae61aca5de82ef687e8d783c9ef | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.68e-04 | 196 | 32 | 3 | 7c8aa5853d7096628e35af665097c0299c329753 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM1-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.68e-04 | 196 | 32 | 3 | f60b220ed117bcc33e0f7bbf5b53d3b1422ebaca | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.73e-04 | 197 | 32 | 3 | 16758f181ef07c60aee63072e1da9572c5c85414 | |
| ToppCell | tumor_Lung-T/NK_cells-CD4+_Th|T/NK_cells / Location, Cell class and cell subclass | 3.73e-04 | 197 | 32 | 3 | 0379d67beeba5864b5ffe5d282643204a112754f | |
| ToppCell | (4)_Endothelial_cells-(41)_EC-arteriolar|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.73e-04 | 197 | 32 | 3 | 482e3f8926880afed88ed37553ed2b5ed58b8c99 | |
| ToppCell | P03-Mesenchymal-myocytic_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.73e-04 | 197 | 32 | 3 | 079db904a08743b3c555cb7b3f5fb5c978dde25a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.73e-04 | 197 | 32 | 3 | 12370ee857fddf1cf26196b23c21b68dcea48eb3 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.73e-04 | 197 | 32 | 3 | 755a53d4206354583bc5b76b63a0b1c9892b7382 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.73e-04 | 197 | 32 | 3 | af819b0561c8db582c5b466d804153d69d3297e0 | |
| ToppCell | BAL-Mild-Myeloid-MoAM|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.73e-04 | 197 | 32 | 3 | 0f40dd3530eb8d02e79b32f942efe3b65b8f6ee6 | |
| ToppCell | 11.5-Distal-Epithelial|Distal / Age, Tissue, Lineage and Cell class | 3.73e-04 | 197 | 32 | 3 | ae9505ae7e6c5e8c280f9bfb1ba79ab5bd8895e3 | |
| ToppCell | BAL-Mild-Myeloid-MoAM|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.73e-04 | 197 | 32 | 3 | a6aa5991d566c28440f7e24a30933e69669064f2 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.79e-04 | 198 | 32 | 3 | ad9fb53cd216af9bc9998d6b3bd0255b45e0dbfb | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.79e-04 | 198 | 32 | 3 | a41d0a6e5f9f30a48bb7fed431a3e8257f62f955 | |
| ToppCell | distal-Hematologic-Alveolar_Macrophage-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.79e-04 | 198 | 32 | 3 | cd56124ff98a194ec030588dac684535a31cb5e4 | |
| ToppCell | 3'_v3-GI_small-bowel-Mast-Mast_cells|GI_small-bowel / Manually curated celltypes from each tissue | 3.79e-04 | 198 | 32 | 3 | 920d2e6603a06c2e8dcb6be127202d222c662bca | |
| ToppCell | mLN-T_cell-Th17|T_cell / Region, Cell class and subclass | 3.79e-04 | 198 | 32 | 3 | efdc9515dd9fb20ef9c8ddc106d88cbdde7d6ea2 | |
| ToppCell | distal-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.79e-04 | 198 | 32 | 3 | 6aef5f5f89b508b214e1ab1876a743dedda0553b | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.79e-04 | 198 | 32 | 3 | 7c4993be089979e79ca1a160c0c4059c422eac6d | |
| ToppCell | 3'_v3-GI_small-bowel-Mast|GI_small-bowel / Manually curated celltypes from each tissue | 3.79e-04 | 198 | 32 | 3 | 807e3ed34739eca159dd0970f884b073e588c649 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.79e-04 | 198 | 32 | 3 | edf3e1c2be9df5690492b9c8fc25e7e48ed5c92c | |
| ToppCell | Caecum-T_cell-Th1|T_cell / Region, Cell class and subclass | 3.85e-04 | 199 | 32 | 3 | 13a80e6d3cf9c831edbe0644545071153e35f82b | |
| ToppCell | (04)_Interm._basal>secr.|World / shred by cell type by condition | 3.85e-04 | 199 | 32 | 3 | ed399244433f781fc291a9bff16825b8a3ca294f | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-04 | 200 | 32 | 3 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| Disease | Alcohol withdrawal syndrome | 2.98e-05 | 8 | 31 | 2 | C0236663 | |
| Disease | Neoplasm Metastasis | 7.66e-05 | 217 | 31 | 4 | C0027627 | |
| Disease | Malignant neoplasm of breast | 1.01e-04 | 1074 | 31 | 7 | C0006142 | |
| Disease | Mammary Neoplasms, Human | 2.03e-04 | 525 | 31 | 5 | C1257931 | |
| Disease | Mammary Carcinoma, Human | 2.03e-04 | 525 | 31 | 5 | C4704874 | |
| Disease | Mammary Neoplasms | 2.06e-04 | 527 | 31 | 5 | C1458155 | |
| Disease | Breast Carcinoma | 2.27e-04 | 538 | 31 | 5 | C0678222 | |
| Disease | Nephrotic Syndrome | 3.69e-04 | 27 | 31 | 2 | C0027726 | |
| Disease | obesity (implicated_via_orthology) | 1.48e-03 | 215 | 31 | 3 | DOID:9970 (implicated_via_orthology) | |
| Disease | Major Depressive Disorder | 2.09e-03 | 243 | 31 | 3 | C1269683 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GPGGDYAAMGACPAS | 1271 | P21860 | |
| MQGAGGYDSTMPYGC | 261 | O43823 | |
| GYDSTMPYGCGRSQP | 266 | O43823 | |
| SGPSPRRMGGYYAGE | 316 | C9J069 | |
| AGDMPYPCLGAYGTS | 221 | P80365 | |
| CYAAMFGPKGFGRGG | 56 | P50238 | |
| SGPSPGDGAMGYGYE | 286 | P43268 | |
| PYELCGGMAYCGPQV | 66 | Q06416 | |
| GPGEGRSYPDYMYGS | 131 | P31274 | |
| GAGNYGMCGRAYSPR | 446 | Q9HCC0 | |
| SGTIMYQGGRGPDGY | 266 | P55073 | |
| MAAYSYRPGPGAGPG | 1 | O75340 | |
| MAEYYRPGPAGSGGC | 201 | Q93074 | |
| DYGMGPGRSGPYGVT | 1801 | Q93074 | |
| MASYPYRQGCPGAAG | 1 | Q9UBV8 | |
| PAGGGYGRAAPCDYG | 61 | P17509 | |
| YGCGTAAFPYPMMHG | 156 | Q7Z6I8 | |
| YEGTSSIPGPGYCMG | 41 | P11511 | |
| QDCMPGYYGDPTNGG | 1041 | Q5VV63 | |
| PYGDCYRMAEPAAGG | 526 | Q8NBF1 | |
| PAGYLLYCPCMGRFG | 31 | Q9H488 | |
| GGYGGLDMMPAGYDA | 241 | Q12947 | |
| GPQGPYYCGVGADRA | 156 | P15104 | |
| DYMYSAQGNGGGPPR | 161 | Q96KG9 | |
| AGGGGQGPMPRVRYY | 31 | Q9H3S1 | |
| MSASPSGYGGLPYGA | 266 | O00570 | |
| YGGGCHGCLMSRDPY | 496 | O75326 | |
| PGLDYGGYEPMDSGG | 46 | Q9UPU5 | |
| RCMYPGGQGDYAGFP | 531 | O43314 | |
| TMCPEGRYGHPGYPA | 771 | Q63HR2 | |
| AFRCMYPGGQGDYAG | 541 | Q6PFW1 | |
| GPDGDFSSPGSGCYM | 246 | Q9Y493 | |
| GMDRDYGPGSYGGMD | 21 | Q5BKZ1 | |
| SPYQSGAGPMGCYPG | 386 | Q00653 |